Skip to main content

Press Release - Mankind Pharma Reinvents Global Supply Chain and Procurement with Accenture

 Mankind Pharma Reinvents Global Supply Chain and Procurement with Accenture

 

New Delhi, February 16, 2026: Mankind Pharma, India’s fourth-largest pharmaceutical company, has completed a large-scale, multi-year transformation of its global supply chain and strategic procurement function to strengthen access to medicines, improve supply reliability, and support disciplined, scalable growth. Delivered in collaboration with Accenture, the integrated initiative embeds digitally enabled operating models, powered by advanced analytics and AI, across Mankind Pharma’s procurement, manufacturing and distribution networks. This is enhancing the company’s ability to manage demand volatility, supply disruptions, and regulatory complexities at scale.

 

 This transformation brings together two critical operating pillars into a unified, end-to-end backbone that tightly links planning intelligence with execution performance. Mankind Pharma has reimagined its global supply chain through an integrated planning platform that connects demand forecasting, manufacturing, inventory, and distribution within a near real-time decision framework across more than 25 international markets. Powered by advanced analytics and AI-augmented insights, the platform has strengthened forecast accuracy, improved cross-functional alignment, and enabled faster, more responsive planning and execution. In parallel, the company completed an 18-month overhaul of its strategic sourcing and procurement function, reinforcing cost discipline, governance, and supplier collaboration through standardized processes, digital automation, and analytics-led decision-making.

 

 The impact has been tangible and measurable. The customized planning and execution platform deployed across 30 manufacturing facilities and more than 50 distribution centers, has reduced drug stock-outs by 75 per cent and optimized inventory by up to 20 per cent across Mankind Pharma’s global distribution network. The platform has enhanced decision-making, and improved coordination across commercial, manufacturing and supply teams. This has strengthened supply chain performance at scale while maintaining the highest standards of quality and compliance.

 

 Alongside this, the procurement transformation initiative has structurally elevated sourcing as a core business capability for Mankind Pharma. The company clarified sourcing ownership and standardized end-to-end processes to improve efficiency and governance. Digital tools now automate routine activities, enabling teams to focus on strategic decisions and supplier partnerships, while advanced analytics give leadership sharper visibility into spending, supplier performance and supply chain risks. Together, these changes have delivered sustainable cost efficiencies while safeguarding quality, compliance, and supply continuity.

 

 Arjun Juneja, Chief Operating Officer, Mankind Pharma Ltd., said: “Ensuring uninterrupted access to quality medicines today requires value chains that are intelligent, digitally enabled, and resilient by design. At Mankind, we have reimagined the traditional value chain into a life chain—built to serve patients, not just processes. By integrating demand, procurement, manufacturing, inventory management, and execution through advanced analytics and AI-augmented insights, we have strengthened our ability to anticipate demand, manage volatility, and respond with speed and precision across markets. This transformation goes beyond efficiency, delivering sharper visibility, stronger control, and quality and compliance by design. It enables us to scale responsibly and sustainably, reinforcing our commitment to Availability, Quality, and Affordability, while building long-term resilience into our operations.”

 

Jignesh Vora, managing director and lead - Life Sciences, Accenture in India, said, “Working closely with Mankind Pharma, Accenture helped reimagine and strengthen the company’s operating model for the long term. By combining AI-led, data-driven capabilities with deep life sciences and supply chain expertise, we enabled a more predictive and resilient supply chain and procurement ecosystem—driving better decision-making at scale, improving access to medicines, and supporting sustainable growth in a volatile and regulated environment.”

 

 This global supply chain and strategic procurement transformation reinforces Mankind Pharma’s commitment to operational excellence, disciplined execution, and long-term resilience, while remaining anchored to its purpose of improving access to quality and affordable medicines. As healthcare systems continue to evolve, the transformation positions the company to respond with agility, consistency, and scale, strengthening trust among patients, partners, and stakeholders across India and global markets.

 

About Mankind Pharma

Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, gynecology, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. Following the acquisition of Bharat Serums and Vaccines Limited, Mankind Pharma has further strengthened its leadership in the domestic women’s health segment. Mankind's distribution network includes a robust field force of 17,700+ professionals, and a reach extending to over five lakh doctors across urban and rural markets. The company has 32 manufacturing facilities manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 6 dedicated R&D facilities backed by more than 730 scientists.

For more information, visit www.mankindpharma.comor contact:

Natasha Raj - 9205057627 - natasha.raj@mankindpharma.com

Labels:

Comments

Post a Comment

Popular posts from this blog

3 books you should read if you like gambling

By playing, a person's body remains active. He gets new energy from these games for other tasks. But in recent times, information and technology have advanced so much that various types of games are easily accessible through the Internet. Cricket is no exception. But if these games bring us happiness, then we have to answer no. These include playing cards and card games, carom during the holidays, and fun times. Cards originated in China. The cards are used to play various sitting games. In addition to games, cards are also used in magic, prophecy, and bungalows of cards. They are mainly used in gambling. People are so mentally disturbed that they can’t easily escape once they get mad in gambling with https://www.10cric.com/ . The person who knows gambling can automatically get knowledge about betting. Because gambling and betting are two sides of one coin, many houses have been destroyed due to gambling. But some gamblers earn a lot because of gambling and betting! ...
96 comments
Read more

Is studying abroad a boon or a bane?

We have always had a debate when it comes to the topic - "Is studying abroad a boon or a bane?" The ideas differ from person to person. If you ask me, I would surely say that Studying Abroad is certainly a boon. Why is that? India is home to many universities which are known worldwide. Having said that, we must also accept the fact that none of them are in Top 20 at least. While there are many factors that attributes to this, when a person has the means to afford it combined with interest and talent, I do not see the reason as to why one shouldn't be educated abroad? While few study for their status symbol, majority of them predominantly study abroad to enhance their career. There is no doubt in it. Take a look at this brilliant video before we could proceed further. Having said that, the option isn't available to all who wanted to go out of India. The major hindrance for us is clearing the English tests which were being conducted across the glob...
55 comments
Read more

WeeBeeSocial –Providing the Mojo for Digital Marketing Initiatives

A long time ago, the quest was to discover new lands and habitats. And now, as humanity has travelled far and wide, we search for new experiences in the digital world. The digital space is where brands and customers meet, communicate and interact to forge new relationships. The success of these interactions depends on the experiences that brands create for their target audience. This is no easy task and there are only a few that have mastered the art and science of digital marketing. One such entity is  WeBeeSocial , a leading digital marketing agency based in New Delhi. The folks at WeBeeSocial breathe digital and their one and only goal is to help brands create super-rich experiences for theircustomers. A full service creative digital agency,  WeBeeSocial  is where creativity and technology merge to create powerful, immersive experiences in the digital space. WeBeeSocial is the first choice for many leading brands, as it offers a comprehensive range of digital...
23 comments
Read more